Key findings
- 2834 people across Australia participated in the TraX study during the reporting period. Most participants were from New South Wales (83.8%).
- At study entry, 22.4% of participants reported being unvaccinated against MPOX, 50.0% had received one and 27.6% had received two MPOX vaccinations.
- As at 26 March 2023, the proportion of people who reported being unvaccinated against MPOX had reduced by half to 9.7%, leaving 275 participants unvaccinated. The proportion who reported having received one MPOX vaccination also fell to 12.2% and the proportion who received both MPOX vaccinations increasing to 78.1%.
- At study entry, nine participants reported prior MPOX infection.
